Findings

What do systematic reviews say?

54 questions · 58 findings · 3 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 20 · 34.5%GRADE not reported 1 · 1.7%Very low 22 · 37.9%Low 13 · 22.4%Moderate 2 · 3.4%High 0 · 0%

Miscellaneous treatment vs miscellaneous treatments

Outcomes ( · people with facial burns

The review found no eligible studies for this question.

1 finding from 1 review

Topical treatment for facial burns 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Miscellaneous treatment vs miscellaneous treatments

Time to complete healing · people with facial burns

1 finding from 1 review

Topical treatment for facial burns 2020 · Cochrane Headline outcomes only
no estimate extracted
40 participants
Low

Miscellaneous treatment vs miscellaneous treatments

Proportion of wounds healed · people with facial burns

Miscellaneous treatment may leads to higher proportion of wounds completely healed in 14 days (14 days) compared with miscellaneous treatment (low certainty).

1 finding from 1 review

Topical treatment for facial burns 2020 · Cochrane Headline outcomes only
RR 4.77 [1.87, 12.15]
43 participants
Low

Miscellaneous treatment vs miscellaneous treatments

Change in wound surface area over time or partial healing (> 95%) (12 months) · people with facial burns

1 finding from 1 review

Topical treatment for facial burns 2020 · Cochrane Headline outcomes only
no estimate extracted
2011 participants
GRADE not reported

Miscellaneous treatment vs miscellaneous treatments

Infection ( · people with facial burns

1 finding from 1 review

Topical treatment for facial burns 2020 · Cochrane Headline outcomes only
no estimate extracted
43 participants
Very low

Melatonin vs placebo or no treatment

Leaving the study early · patients with antipsychotic‐induced tardive dyskinesia

1 finding from 1 review

Miscellaneous treatments for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 54 participants
Very low

Alarm vs miscellaneous treatments

Proportion of children achieving 14 consecutive dry nights by the end of treatment · children with nocturnal enuresis

It is very uncertain whether alarm changes proportion of children achieving 14 consecutive dry nights by the… compared with miscellaneous treatments (very low certainty).

4 findings from 1 review

Alarm interventions for nocturnal enuresis in children 2020 · Cochrane Headline outcomes only
RR 0.84 [0.55, 1.29]
1 study · 39 participants
Very low
Alarm interventions for nocturnal enuresis in children 2020 · Cochrane Headline outcomes only
RR 3.62 [1.38, 9.5]
2 studies · 116 participants
Very low
Alarm interventions for nocturnal enuresis in children 2020 · Cochrane Headline outcomes only
RR 3 [1.41, 6.39]
1 study · 96 participants
Very low

Show 1 more finding

Alarm interventions for nocturnal enuresis in children 2020 · Cochrane Headline outcomes only
RR 23 [3.19, 165.98]
1 study · 150 participants
Very low

Buspirone vs placebo

Leaving the study early · psychiatric patients (schizophrenia) with antipsychotic‐induced tardive dyskinesia

It is very uncertain whether ANXIOLYTIC ‐ BUSPIRONE changes acceptability of treatment (measured by participants leaving the… compared with PLACEBO (very low certainty).

1 finding from 1 review

Miscellaneous treatments for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 42 participants
Very low

FATTY ACID ‐ ETHYL‐EPA vs placebo

Leaving the study early · female and male 42 (mean) years old patients with schizophrenia or schizoaffective disorder and antipsychotic‐induced tardive dyskinesia

It is very uncertain whether FATTY ACID ‐ ETHYL‐EPA changes acceptability of treatment (measured by participants leaving the… compared with PLACEBO (very low certainty).

1 finding from 1 review

Miscellaneous treatments for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
RR 0
1 study · 84 participants
Very low

Ginkgo biloba vs placebo

Leaving the study early · male 45.2 (mean) years old patients with schizophrenia and antipsychotic‐induced tardive dyskinesia

It is very uncertain whether HERB ‐ GINKGO BILOBA changes acceptability of treatment (measured by participants leaving the… compared with PLACEBO (very low certainty).

1 finding from 1 review

Miscellaneous treatments for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
RR 0.25 [0.03, 2.22]
1 study · 157 participants
Very low

POLYPEPTIDE ‐ CERULETIDE vs placebo

Leaving the study early · female and male 55‐59 year old (mean) patients with various psychiatric conditions and antipsychotic‐induced tardive dyskinesia

It is very uncertain whether POLYPEPTIDE ‐ CERULETIDE changes acceptability of treatment (measured by participants leaving the… compared with PLACEBO (very low certainty).

1 finding from 1 review

Miscellaneous treatments for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
RR 1.09 [0.49, 2.4]
1 study · 85 participants
Very low

ALKALOID ‐ DIHYDROGENATED ERGOT ALKALOIDS vs placebo

Leaving the study early · female and male 59‐80 (mean) years old patients with antipsychotic‐induced tardive dyskinesia

It is very uncertain whether ALKALOID ‐ DIHYDROGENATED ERGOT ALKALOIDS changes acceptability of treatment (measured by participants leaving the… compared with PLACEBO (very low certainty).

1 finding from 1 review

Miscellaneous treatments for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
RR 0.33 [0.02, 7.32]
2 studies · 48 participants
Very low

HYPNOSIS or RELAXATION vs TAU

Leaving the study early · female and male 35 (mean) years old patients with schizophrenia and tardive dyskinesia, acute extrapyramidal symptoms, and/or…

1 finding from 1 review

Miscellaneous treatments for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 15 participants
Very low

Levetiracetam vs placebo

Leaving the study early · patients with antipsychotic‐induced tardive dyskinesia

It is very uncertain whether ANTIEPILEPTIC ‐ LEVETIRACETAM changes acceptability of treatment (measured by participants leaving the… compared with PLACEBO (very low certainty).

1 finding from 1 review

Miscellaneous treatments for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
RR 1.01 [0.46, 2.22]
2 studies · 119 participants
Very low

Melatonin vs placebo or no treatment

Tardive dyskinesia: No clinically important improvement · patients with antipsychotic‐induced tardive dyskinesia

HORMONE ‐ MELATONIN showed no clear difference in tardive dyskinesia: No clinically important improvement compared with PLACEBO OR NO TREATMENT (low certainty).

1 finding from 1 review

Miscellaneous treatments for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
RR 0.89 [0.71, 1.12]
2 studies · 32 participants
Low

Melatonin vs placebo or no treatment

Tardive dyskinesia: Deterioration of symptoms · patients with antipsychotic‐induced tardive dyskinesia

HORMONE ‐ MELATONIN showed no clear difference in tardive dyskinesia: Deterioration of symptoms compared with PLACEBO OR NO TREATMENT (low certainty).

1 finding from 1 review

Miscellaneous treatments for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
RR 0.22 [0.01, 4.05]
1 study · 19 participants
Low

Melatonin vs placebo or no treatment

Adverse effects · patients with antipsychotic‐induced tardive dyskinesia

1 finding from 1 review

Miscellaneous treatments for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 54 participants
Low

Melatonin vs placebo or no treatment

Social confidence, social inclusion, social networks, or personalised quality of life ‐ not reported · patients with antipsychotic‐induced tardive dyskinesia

The review found no eligible studies for this question.

1 finding from 1 review

Miscellaneous treatments for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Alarm vs miscellaneous treatments

Mean number of wet nights a week · children with nocturnal enuresis

1 finding from 1 review

Alarm interventions for nocturnal enuresis in children 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 33 participants
Very low

Alarm vs miscellaneous treatments

Proportion of children dry at · children with nocturnal enuresis

It is very uncertain whether alarm changes proportion of children dry at compared with miscellaneous treatments (very low certainty).

2 findings from 1 review

Alarm interventions for nocturnal enuresis in children 2020 · Cochrane Headline outcomes only
RR 0.48 [0.25, 0.92]
1 study · 33 participants
Very low
Alarm interventions for nocturnal enuresis in children 2020 · Cochrane Headline outcomes only
RR 3 [1.18, 7.6]
1 study · 96 participants
Very low